Your session is about to expire
← Back to Search
Behavioral Intervention
Online relapse prevention therapy (eRPT) for Alcoholism
N/A
Recruiting
Led By Nazanin Alavi, MD
Research Sponsored by Dr. Nazanin Alavi
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (pre treatment), week 5 (mid treatment), week 10 (post treatment)
Awards & highlights
Study Summary
This trial will compare an online cognitive behavioural therapy (e-RPT) to traditional face-to-face therapy for alcohol use disorder (AUD). The aim is to create a more cost-effective, accessible form of treatment to address AUD in the general population.
Who is the study for?
This trial is for adults who can speak and read English, have mild to moderate Alcohol Use Disorder (AUD) as per DSM-5, are ready to stop drinking or have stopped in the last 30 days, and have reliable internet access. It's not for those with severe mental disorders or substance use issues, other ongoing AUD treatments, heavy drinkers beyond a set limit, or individuals with acute psychiatric emergencies.Check my eligibility
What is being tested?
The study compares online relapse prevention therapy (e-RPT) with traditional face-to-face sessions for treating AUD. Both methods involve ten sessions covering similar content but delivered differently—one through pre-designed modules plus therapist feedback online and the other in person.See study design
What are the potential side effects?
Since this trial involves psychological therapy rather than medication, typical side effects associated with drugs aren't expected. However, participants may experience emotional discomfort addressing their alcohol use during therapy.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline (pre treatment), week 5 (mid treatment), week 10 (post treatment)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (pre treatment), week 5 (mid treatment), week 10 (post treatment)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in daily drinking using a Drink diary
Secondary outcome measures
Coping behaviours and thoughts changes from baseline using the Coping Behaviors Inventory (CBI)
Mental Depression
Efficiency of therapist's time comparing time spent writing personalized feedback to time spent conducting the face-to-face sessions
+3 moreOther outcome measures
Qualitative assessment of treatment engagement through the program, by looking at module completion, and adherence to the program
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Online relapse prevention therapy (eRPT)Experimental Treatment1 Intervention
Online relapse preventiontherapy
Group II: Face-to-face relapse prevention therapy (RPT)Active Control1 Intervention
Face-to-face in-person relapse prevention therapy
Find a Location
Who is running the clinical trial?
Dr. Nazanin AlaviLead Sponsor
12 Previous Clinical Trials
1,056 Total Patients Enrolled
Queen's UniversityLead Sponsor
365 Previous Clinical Trials
120,357 Total Patients Enrolled
Nazanin Alavi, MDPrincipal InvestigatorQueen's University
1 Previous Clinical Trials
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a serious drug addiction according to the DSM-5.If you are a man and drink more than four alcoholic drinks per day or fourteen drinks per week, or if you are a woman and drink more than three alcoholic drinks per day or seven drinks per week in the last month, you will be excluded from the trial.You are currently experiencing episodes of extreme happiness, excitement or irritability.You have been diagnosed with a mild to moderate alcohol use disorder according to the DSM-5.You have regular and dependable access to the internet.You are currently experiencing severe mental illness with symptoms such as delusions or hallucinations.You are currently having thoughts of hurting yourself or others.You are currently considering or have already stopped drinking alcohol in the past month.
Research Study Groups:
This trial has the following groups:- Group 1: Online relapse prevention therapy (eRPT)
- Group 2: Face-to-face relapse prevention therapy (RPT)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many volunteers have taken part in this clinical investigation?
"Affirmative. Clinicaltrials.gov documents show that, since its inception on October 1st 2022 and most recent update on the 11th of October, this trial is now recruiting 60 individuals from a single medical facility."
Answered by AI
Who meets the qualifications to participate in this research project?
"Prerequisites for joining this trial include an alcohol use disorder diagnosis and being betwixt the ages of 18 and 64. The research team is actively seeking 60 participants to join their study."
Answered by AI
Is this trial considering applicants aged 45 and above?
"Eligible candidates for this medical trial must be of legal age and under 64 years old."
Answered by AI
Are there still openings for prospective participants in this clinical trial?
"The details on clinicaltrials.gov suggest that this medical trial is accessible to potential volunteers, as it was initially posted in October 1st 2022 and underwent its most recent amendment a few weeks later."
Answered by AI
Who else is applying?
What state do they live in?
Minnesota
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
0
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger